BACKGROUND: The blood pressure of many treated hypertensive patients remains above recommended target levels. This discrepancy may be related to general practitioners' (GPs') actions. AIM: To assess clinical performance of GPs in blood pressure control in treated hypertensive patients and to explore the influence of patient and GP characteristics on clinical performance. DESIGN OF STUDY: Cross-sectional study conducted on 195 GPs with invitations to participate made via bulletins and by letter. SETTING: One hundred and thirty-two practices in the southern half of The Netherlands from November 1996 to April 1997. METHOD: Performance criteria were selected from Dutch national hypertension guidelines for general practice. GPs completed self-report forms immediately after follow-up visits of hypertensive patients treated with antihypertensive medication. RESULTS: The GPs recorded 3526 follow-up visits. In 63% of these consultations the diastolic blood pressure (DBP) was 90 mmHg or above. The median performance rates of the GPs were less than 51% for most of the recommended actions, even at a DBP of > or = 100 mmHg. Performance of non-pharmacological actions increased gradually with increasing DBP; prescribing an increase in antihypertensive medication and making a follow-up appointment scheduled within six weeks rose steeply at a DBP of > or = 100 mmHg. Patient and GP characteristics contributed little to clinical performance. Action performance rates varied considerably between GPs. CONCLUSION: GPs seem to target their actions at a DBP of below 100 mmHg, whereas guidelines recommend targeting at a DBP of below 90 mmHg.
BACKGROUND: The blood pressure of many treated hypertensivepatients remains above recommended target levels. This discrepancy may be related to general practitioners' (GPs') actions. AIM: To assess clinical performance of GPs in blood pressure control in treated hypertensivepatients and to explore the influence of patient and GP characteristics on clinical performance. DESIGN OF STUDY: Cross-sectional study conducted on 195 GPs with invitations to participate made via bulletins and by letter. SETTING: One hundred and thirty-two practices in the southern half of The Netherlands from November 1996 to April 1997. METHOD: Performance criteria were selected from Dutch national hypertension guidelines for general practice. GPs completed self-report forms immediately after follow-up visits of hypertensivepatients treated with antihypertensive medication. RESULTS: The GPs recorded 3526 follow-up visits. In 63% of these consultations the diastolic blood pressure (DBP) was 90 mmHg or above. The median performance rates of the GPs were less than 51% for most of the recommended actions, even at a DBP of > or = 100 mmHg. Performance of non-pharmacological actions increased gradually with increasing DBP; prescribing an increase in antihypertensive medication and making a follow-up appointment scheduled within six weeks rose steeply at a DBP of > or = 100 mmHg. Patient and GP characteristics contributed little to clinical performance. Action performance rates varied considerably between GPs. CONCLUSION: GPs seem to target their actions at a DBP of below 100 mmHg, whereas guidelines recommend targeting at a DBP of below 90 mmHg.
Authors: D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz Journal: N Engl J Med Date: 1998-12-31 Impact factor: 91.245
Authors: L Ramsay; B Williams; G Johnston; G MacGregor; L Poston; J Potter; N Poulter; G Russell Journal: J Hum Hypertens Date: 1999-09 Impact factor: 3.012
Authors: C G Isles; L M Walker; G D Beevers; I Brown; H L Cameron; J Clarke; V Hawthorne; D Hole; A F Lever; J W Robertson Journal: J Hypertens Date: 1986-04 Impact factor: 4.844
Authors: Melanie Inkster; Alan Montgomery; Peter Donnan; Tom MacDonald; Frank Sullivan; Tom Fahey Journal: Br J Gen Pract Date: 2005-12 Impact factor: 5.386
Authors: Brian McKinstry; Janet Hanley; David Heaney; Lucy McCloughan; Rob Elton; David J Webb Journal: Br J Gen Pract Date: 2006-11 Impact factor: 5.386
Authors: Jarir Atthobari; Taco B M Monster; Paul E de Jong; Lolkje T W de Jong-van den Berg Journal: Br J Clin Pharmacol Date: 2004-03 Impact factor: 4.335
Authors: Patrik Midlöv; Rickard Ekesbo; Lennart Johansson; Sofia Gerward; Kristin Persson; Christina Nerbrand; Bo Hedblad Journal: Scand J Prim Health Care Date: 2008 Impact factor: 2.581
Authors: B D Frijling; C M Lobo; M E J L Hulscher; R P Akkermans; B B van Drenth; A Prins; J C van der Wouden; R P T M Grol Journal: Qual Saf Health Care Date: 2003-06